$KDOZF Balance Sheet | Understand Stock

$KDOZF

$0.09 -$0.00 (0.68%) Close

$KDOZF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018
Current assets:
Cash
Accounts receivable, less allowance for doubtful accounts $356,167 (2024 - $220,733) (Note 3)
Prepaid expenses (Note 4)
Total Current Assets
Total equipment
Deferred tax asset, less valuation allowance of $275,846 (December 31, 2017 - $102,809) (Note 10)
Goodwill and identified intangible assets (Note 3)
Goodwill (Note 7)
Intangible assets (Note 6)
Operating lease right-of-use assets (Note 13)
Long term cash equivalent
Security deposit
Total Assets
Current liabilities:
Accounts payable
Accrued liabilities
Accounts payable and accrued liabilities - related party (Note 13)
Derivative liability – warrants (Note 2e and 9)
Accounts payable and accrued liabilities - related party (Note 15)
Accounts payable and accrued liabilities - related party (Note 14)
Derivative liability – warrants (Note 2i and 10)
Government CEBA current loan (Note 9)
Operating lease liabilities – current portion (Note 13)
Short term loan (Note 7)
Total Current Liabilities

Deferred tax liability
Deferred tax liability (Note 13)
Government CEBA long term loan (Note 9)
Operating lease liabilities - non-current portion as at end of period
Total Liabilities
Stockholders’ Equity (Note 9):
Common stock, no par value, unlimited shares authorized, 131,424,989 shares issued and outstanding (December 31, 2020 - 131,124,989)
Common stock, no par value, unlimited shares authorized, 131,304,499 shares issued and outstanding (December 31, 2024 - 131,304,499)
Treasury shares, nil shares (December 31, 2022 – 41,500)
Accumulated deficit
Accumulated other comprehensive income: Foreign currency translation adjustment
Total Stockholders’ Equity

Total Liabilities and Stockholders’ Equity

Comments